Discontinuation of immunosuppression in patients with immune‐mediated drug‐induced liver injury or idiopathic autoimmune hepatitis: A case–control study

BACKGROUND AND AIM: Drug‐induced liver injury (DILI) may present with autoimmune features and require immunosuppressive therapy (IST) to reach biochemical response. Discontinuation of IST without hepatitis relapse may be more frequent in these patients as compared to patients with classical autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassoun, Jeremy, Goossens, Nicolas, Restellini, Sophie, Ramer, Lucas, Ongaro, Marie, Giostra, Emiliano, Hadengue, Antoine, Rubbia‐Brandt, Laura, Spahr, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958343/
https://www.ncbi.nlm.nih.gov/pubmed/36852147
http://dx.doi.org/10.1002/jgh3.12862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958343/
https://www.ncbi.nlm.nih.gov/pubmed/36852147
http://dx.doi.org/10.1002/jgh3.12862

Ejemplares similares